GlassScriptPhysician profile
Anthony W Morton
NPI 1578504478
$5,114.70
in general payments reported to CMS, 2019-2025
38 companies · $642 in 2025
The $642 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $171 · 2021: $516 · 2022: $1,073 · 2023: $1,354 · 2024: $991 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,986.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $932.36 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $713.82 | 2019-2025 | Freestyle Libre 3, Eterna, Proclaim |
| Pfizer INC. | $389.66 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $338.42 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $334.58 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $309.80 | 2020-2025 | Jardiance, Mounjaro, Emgality |
| Abbvie INC. | $217.66 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $216.22 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $182.84 | 2021-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.46 | 2019-2023 | Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $157.67 | 2021-2025 | |
| Amgen INC. | $149.26 | 2019-2025 | Otezla, Repatha |
| Sanofi-Aventis U.S. LLC | $130.94 | 2019-2023 | |
| Exact Sciences Corporation | $96.92 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $93.26 | 2019-2023 | Xarelto |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.